Clinical Trial 45966

Garden Grove, CA 92845


This is a multicenter, open-label, adaptive, repeat-dose study to evaluate the safety, tolerability, and pharmacokinetics of iloperidone long-acting injection (LAI) in patients with schizophrenia.

  • Willing and able to provide written informed consent.
  • Male or female patients 18 to 65 years of age (inclusive).
  • Clinical diagnosis of schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorder (DSM-5) for at least 1 year.
  • Symptomatically stable within the past two months.

Qualified Participants May Receive:

Monetary compensation for participating.

Available At:

Collaborative Neuroscience Research, LLC

Garden Grove, California, United States, 92845

Contact: 714-891-0971

Prinicpal Investigator: David Walling


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.